This page shows the latest Foresite Capital news and features for those working in and with pharma, biotech and healthcare.
The SPAC is sponsored by Foresite Capital, a healthcare and life sciences investment firm based in the US. ... Most of the money raised will come from the SPAC itself, with approximately $75m to be raised through a private round with backers including
The financing was led by Deerfield Management, with significant new investments from a host of other investors, including RA Capital Management, Venrock, Foresite Capital and Perceptive Advisors.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
No results were found
Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....